Catalytic RAG1 mutants obstruct V(D)J recombination in vitro and in vivo

Molecular Immunology

Volumn 39, Issue 14, 2003, Pages 871-878

  Furusawa, Tadashi ^a   Hosoe, Misa ^a   Ohkoshi, Katsuhiro ^a   Takahashi, Seiya ^b   Kiyokawa, Nobutaka ^c   Fujimoto, Jun Ichiro ^c   Amemiya, Hiroshi ^c   Suzuki, Seiichi ^c   Tokunaga, Tomoyuki ^a  

^a NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF LIVESTOCK AND GRASSLAND SCIENCE   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

RAG1 mutants; SCID; Xenotransplantation

Indexed keywords

GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN M; RAG1 PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; GENE MUTATION; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN STABILITY; RABBIT; TRANSGENIC MOUSE; WILD TYPE; XENOTRANSPLANTATION;

ANIMALIA; MUS MUSCULUS; ORYCTOLAGUS CUNICULUS;

EID: 0037402561     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(03)00008-7     Document Type: Article

References (45)

1. Aidinis V., Dias D.C., Gomez C.A., Bhattacharyya D., Spanopoulou E., Santagata S. Definition of minimal domains of interaction within the recombination-activating genes 1 and 2 recombinase complex. J. Immunol. 164:2000;5826-5832.
2. Bellon S.F., Rodgers K.K., Schatz D.G., Coleman J.E., Steitz T.A. Crystal structure of the RAG1 dimerization domain reveals multiple zinc-binding motifs including a novel zinc binuclear cluster. Nat. Struct. Biol. 4:1997;586-591.
3. Dai Y., Vaught T.D., Boone J., Chen S.H., Phelps C.J., Ball S., Monahan J.A., Jobst P.M., McCreath K.J., Lamborn A.E., Cowell-Lucero J.L., Wells K.D., Colman A., Polejaeva I.A., Ayares D.L. Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 20:2002;251-255.
4. Enosawa S., Miyashita T., Fujita Y., Suzuki S., Amemiya H., Omasa T., Hiramatsu S., Suga K., Matsumura T. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure. Cell Transplant. 10:2001a;429-433.
5. Enosawa S., Miyashita T., Tanaka H., Li X., Suzuki S., Amemiya H., Omasa T., Suga K., Matsumura T. Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2. Transplant Proc. 33:2001b;1945-1947.
6. Fujino M., Li X.K., Suda T., Hashimoto M., Okabe K., Yaginuma H., Mikoshiba K., Guo L., Okuyama T., Enosawa S., Amemiya H., Amano T., Suzuki S. In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells. Xenotransplantation. 8:2001;115-124.
7. Gao Y., Chaudhuri J., Zhu C., Davidson L., Weaver D.T., Alt F.W. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity. 9:1998a;367-376.
8. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang J., Bronson R.T., Malynn B.A., Bryans M., Zhu C., Chaudhuri J., Davidson L., Ferrini R., Stamato T., Orkin S.H., Greenberg M.E., Alt F.W. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell. 95:1998b;891-902.
9. Gu Y., Seidl K.J., Rathbun G.A., Zhu C., Manis J.P., van der Stoep N., Davidson L., Cheng H.L., Sekiguchi J.M., Frank K., Stanhope-Baker P., Schlissel M.S., Roth D.B., Alt F.W. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity. 7:1997;653-665.
10. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418:2002;41-49.
11. Joazeiro C.A., Wing S.S., Huang H., Leverson J.D., Hunter T., Liu Y.C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science. 286:1999;309-312.
12. Kim D.R., Dai Y., Mundy C.L., Yang W., Oettinger M.A. Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase. Genes Dev. 13:1999;3070-3080.
13. Krause D.S., Theise N.D., Collector M.I., Henegariu O., Hwang S., Gardner R., Neutzel S., Sharkis S.J. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 105:2001;369-377.
14. Lai L., Kolber-Simonds D., Park K.W., Cheong H.T., Greenstein J.L., Im G.S., Samuel M., Bonk A., Rieke A., Day B.N., Murphy C.N., Carter D.B., Hawley R.J., Prather R.S. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science. 295:2002;1089-1092.
15. Landree M.A., Wibbenmeyer J.A., Roth D.B. Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination. Genes Dev. 13:1999;3059-3069.
16. Lei G., Amemiya H., Suzuki S., Goto T., Kokubo T., Miyamoto M., Kimura H. New immunosuppressive reagent, FTY 720, spares immunologic memory. Transpl. Proc. 32:2000;1628.
17. Li W., Chang F.C., Desiderio S. Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination. Mol. Cell Biol. 21:2001;3935-3946.
18. Lin J.M., Landree M.A., Roth D.B. V(D)J recombination catalyzed by mutant RAG proteins lacking consensus DNA-PK phosphorylation sites. Mol. Immunol. 36:1999;1263-1269.
19. Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., Weissman A.M. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11364-11369.
20. Max E.E., Seidman J.G., Leder P. Sequences of five potential recombination sites encoded close to an immunoglobulin kappa constant region gene. Proc. Natl. Acad. Sci. U.S.A. 76:1979;3450-3454.
21. McBlane J.F., van Gent D.C., Ramsden D.A., Romeo C., Cuomo C.A., Gellert M., Oettinger M.A. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell. 83:1995;387-395.
22. McMahan C.J., Difilippantonio M.J., Rao N., Spanopoulou E., Schatz D.G. A basic motif in the N-terminal region of RAG1 enhances V(D)J recombination activity. Mol. Cell Biol. 17:1997;4544-4552.
23. Miyazaki J., Takaki S., Araki K., Tashiro F., Tominaga A., Takatsu K., Yamamura K. Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5. Gene. 79:1989;269-277.
24. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., Papaioannou V.E. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 68:1992;869-877.
25. Noordzij J.G., Verkaik N.S., Hartwig N.G., de Groot R., van Gent D.C., van Dongen J.J. N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements. Blood. 96:2000;203-209.
26. Oettinger M.A. Activation of V(D)J recombination by RAG1 and RAG2. Trends Genet. 8:1992;413-416.
27. Onishi A., Iwamoto M., Akita T., Mikawa S., Takeda K., Awata T., Hanada H., Perry A.C. Pig cloning by microinjection of fetal fibroblast nuclei. Science. 289:2000;1188-1190.
28. Polejaeva I.A., Chen S.H., Vaught T.D., Page R.L., Mullins J., Ball S., Dai Y., Boone J., Walker S., Ayares D.L., Colman A., Campbell K.H. Cloned pigs produced by nuclear transfer from adult somatic cells. Nature. 407:2000;86-90.
29. Rodgers K.K., Bu Z., Fleming K.G., Schatz D.G., Engelman D.M., Coleman J.E. A zinc-binding domain involved in the dimerization of RAG1. J. Mol. Biol. 260:1996;70-84.
30. Roman C.A., Cherry S.R., Baltimore D. Complementation of V(D)J recombination deficiency in RAG-1(-/-) B cells reveals a requirement for novel elements in the N-terminus of RAG-1. Immunity. 7:1997;13-24.
31. Rosengard A.M., Cary N.R., Langford G.A., Tucker A.W., Wallwork J., White D.J. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation. 59:1995;1325-1333.
32. Sadofsky M.J., Hesse J.E., McBlane J.F., Gellert M. Expression and V(D)J recombination activity of mutated RAG-1 proteins. Nucleic Acids Res. 21:1993;5644-5650.
33. Sakano H., Huppi K., Heinrich G., Tonegawa S. Sequences at the somatic recombination sites of immunoglobulin light-chain genes. Nature. 280:1979;288-294.
34. Schatz D.G., Oettinger M.A., Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell. 59:1989;1035-1048.
35. Schwarz K., Gauss G.H., Ludwig L., Pannicke U., Li Z., Lindner D., Friedrich W., Seger R.A., Hansen-Hagge T.E., Desiderio S., Lieber M.R., Bartram C.R. RAG mutations in human B cell-negative SCID. Science. 274:1996;97-99.
36. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A.M.et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:1992;855-867.
37. Silver D.P., Spanopoulou E., Mulligan R.C., Baltimore D. Dispensable sequence motifs in the RAG-1 and RAG-2 genes for plasmid V(D)J recombination. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6100-6104.
38. Steen S.B., Han J.O., Mundy C., Oettinger M.A., Roth D.B. Roles of the "dispensable" portions of RAG-1 and RAG-2 in V(D)J recombination. Mol. Cell Biol. 19:1999;3010-3017.
39. Tonegawa S. Somatic generation of antibody diversity. Nature. 302:1983;575-581.
40. Villa A., Santagata S., Bozzi F., Giliani S., Frattini A., Imberti L., Gatta L.B., Ochs H.D., Schwarz K., Notarangelo L.D., Vezzoni P., Spanopoulou E. Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 93:1998;885-896.
41. Villa A., Sobacchi C., Notarangelo L.D., Bozzi F., Abinun M., Abrahamsen T.G., Arkwright P.D., Baniyash M., Brooks E.G., Conley M.E., Cortes P., Duse M., Fasth A., Filipovich A.M., Infante A.J., Jones A., Mazzolari E., Muller S.M., Pasic S., Rechavi G., Sacco M.G., Santagata S., Schroeder M.L., Seger R., Strina D., Ugazio A., Valiaho J., Vihinen M., Vogler L.B., Ochs H., Vezzoni P., Friedrich W., Schwarz K. VDJ recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 97:2001;81-88.
42. Waterman H., Levkowitz G., Alroy I., Yarden Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274:1999;22151-22154.
43. Yarnell Schultz H., Landree M.A., Qiu J.X., Kale S.B., Roth D.B. Joining-deficient RAG1 mutants block V(D)J recombination in vivo and hairpin opening in vitro. Mol. Cell. 7:2001;65-75.
44. Yokouchi M., Kondo T., Houghton A., Bartkiewicz M., Horne W.C., Zhang H., Yoshimura A., Baron R. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J. Biol. Chem. 274:1999;31707-31712.
45. Zhu C., Bogue M.A., Lim D.S., Hasty P., Roth D.B. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell. 86:1996;379-389.